Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Amino Acids for AKI Prevention in LDLT
NCT07132697Not yet recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Aug 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in acute kidney injury (AKI) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Incidence of early post transplant Acute Kidney Injury at 7 days. Planned start Aug 2025; status: not yet recruiting.
02
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07132697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07132697.